499 related articles for article (PubMed ID: 31435173)
1. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
[TBL] [Abstract][Full Text] [Related]
2. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
3. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
[TBL] [Abstract][Full Text] [Related]
5. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
8. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.
Attallah AM; Omran MM; Attallah AA; Abdelrazek MA; Farid K; El-Dosoky I
Int J Clin Oncol; 2017 Apr; 22(2):332-339. PubMed ID: 27864623
[TBL] [Abstract][Full Text] [Related]
9. Update on biomarkers of hepatocellular carcinoma.
Chaiteerakij R; Addissie BD; Roberts LR
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):237-45. PubMed ID: 24275343
[TBL] [Abstract][Full Text] [Related]
10. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cao L; Cheng H; Jiang Q; Li H; Wu Z
Aging (Albany NY); 2020 Mar; 12(5):4573-4591. PubMed ID: 32167932
[TBL] [Abstract][Full Text] [Related]
11. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
12. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
13. DNA markers in molecular diagnostics for hepatocellular carcinoma.
Su YH; Lin SY; Song W; Jain S
Expert Rev Mol Diagn; 2014 Sep; 14(7):803-17. PubMed ID: 25098554
[TBL] [Abstract][Full Text] [Related]
14. Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi Patients.
Farag RMA; Al Ayobi D; Alsaleh KA; Kwon HJ; EL-Ansary A; Dawoud EA
Asian Pac J Cancer Prev; 2019 Jan; 20(1):215-220. PubMed ID: 30678434
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
[TBL] [Abstract][Full Text] [Related]
16. Novel biomarkers in hepatocellular carcinoma.
De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
Bao H; Su H
Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
[TBL] [Abstract][Full Text] [Related]
18. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects.
Lee SC; Tan HT; Chung MC
World J Gastroenterol; 2014 Mar; 20(12):3112-24. PubMed ID: 24696598
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma.
Yin L; He N; Chen C; Zhang N; Lin Y; Xia Q
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1908-1916. PubMed ID: 31072138
[TBL] [Abstract][Full Text] [Related]
20. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
Wang X; Zhang A; Sun H
Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
